Home
Start
Patient info
Links
Professional info
Publications
Medical press
Publications

Immunotherapy for glioma: getting closer to the clinical arena?
Nov 2011 - Curr. Opin. Neurol.; 24(6):1473-6551 [PMID:22027543]
[Finocchiaro G] [Pellegatta S]

Immunotherapy in human glioblastoma.
Sep 2011 - Rev. Neurol. (Paris); 167(10):0035-3787 [PMID:21885075]
[Szabo AT] [Carpentier AF]

Improvement of dendritic cell therapy in glioblastoma multiforme WHO 4 by Newcastle disease virus
Sep 2011 - 2011 ASCO Annual Meeting; Oral Abstract Session, Developmental Therapeutics - Clinical Pharmacology and Immunotherapy
[Nesselhut ]

Immuntherapie des Glioblastoma multiforme mit dendritischen Zellen
Sep 2011 - Dissertation
[Beez ]

New Perspectives in Glioma Immunotherap.
Aug 2011 - :1873-4286 [PMID:21827420]
[Daga A] [Bottino C] [Castriconi R] [Gangemi R] [Ferrini S]

Engineering the brain tumor microenvironment enhances the efficacy of dendritic cell vaccination: implications for clinical trial design.
Jul 2011 - Clin. Cancer Res.; 17(14):1078-0432 [PMID:21632862]
[Mineharu Y] [King GD] [Muhammad AG] [Bannykh S] [Kroeger KM] [Liu C] [Lowenstein PR] [Castro MG]

Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy.
Apr 2011 - :1537-4513 [PMID:21499132]
[Fadul CE] [Fisher JL] [Hampton TH] [Lallana EC] [Li Z] [Gui J] [Szczepiorkowski ZM] [Tosteson TD] [Rhodes CH] [Wishart HA] [Lewis LD] [Ernstoff MS]

Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy.
Mar 2011 - Clin. Cancer Res.; 17(6):1078-0432 [PMID:21135147]
[Prins RM] [Soto H] [Konkankit V] [Odesa SK] [Eskin A] [Yong WH] [Nelson SF] [Liau LM]

Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma.
Jan 2011 - J. Clin. Oncol.; 29(3):1527-7755 [PMID:21149657]
[Okada H] [Kalinski P] [Ueda R] [Hoji A] [Kohanbash G] [Donegan TE] [Mintz AH] [Engh JA] [Bartlett DL] [Brown CK] [Zeh H] [Holtzman MP] [Reinhart TA] [Whiteside TL] [Butterfield LH] [Hamilton RL] [Potter DM] [Pollack IF] [Salazar AM] [Lieberman FS]

Dendritic cell vaccines to combat glioblastoma.
Apr 2010 - Expert Rev Neurother; 10(4):1744-8360 [PMID:20367199]
[Wheeler CJ]

Technical advancement in regulatory T cell isolation and characterization using CD127 expression in patients with malignant glioma treated with autologous dendritic cell vaccination.
Jan 2010 - J. Immunol. Methods; 352(1-2):1872-7905 [PMID:19874827]
[Ardon H] [Verbinnen B] [Maes W] [Beez T] [Van Gool S] [De Vleeschouwer S]

Dendritic cell vaccines for brain tumors.
Nov 2009 - Neurosurg. Clin. N. Am.; 21(1):1558-1349 [PMID:19944973]
[Kim W] [Liau LM]

Heat shock proteins in glioblastomas.
Nov 2009 - Neurosurg. Clin. N. Am.; 21(1):1558-1349 [PMID:19944971]
[Yang I] [Fang S] [Parsa AT]

Monitoring immune responses after glioma vaccine immunotherapy.
Nov 2009 - Neurosurg. Clin. N. Am.; 21(1):1558-1349 [PMID:19944978]
[Jian B] [Yang I] [Parsa AT]

Heat-shock protein vaccines as active immunotherapy against human gliomas.
Nov 2009 - Expert Rev Anticancer Ther; 9(11):1744-8328 [PMID:19895242]
[Yang I] [Han S] [Parsa AT]

Sort order:


Topic:


Search term:
78 entries found (6 pages):